Solid-state NMR spectroscopy and its pharmaceutical use;Szilárdfázisú NMR spektroszkópia és gyógyszerészeti alkalmazása

Acta Pharmaceutica Hungarica

Volumn 80, Issue 1, 2010, Pages 18-45

  Attila, Marosi ^a   Zsófia, Szalay ^b   Adam, Demeter ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

Author keywords

Amorphous materials; Cross polarization; MAS; Polymorphism; Solid state NMR

Indexed keywords

ANALYTIC METHOD; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SOLID STATE;

EID: 77950937966     PISSN: 00016659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. http://nobelprize.org/nobel-prizes - hozzáférés: 2010-03-15.
2. Bloch, F., Hansen, W. W., Packard, M.: Phys Rev 69, 127. (1946).
3. Purcell, E. M., Torrey, H. C., Pound, R. V.: Phys Rev 69, 37-38. (1946).
4. Sohár, P.: Az NMR-sztori. Magyar Kémiai Folyóirat - Elõadások 109-110, 120-126. (1989).
5. Pake, G. E.: J Chem Phys 16, 327-336. (1948).
6. Andrew, E. R., Bradbury, A., Fades, R. G.: Nature 182, 1659. (1958).
7. Bugay, D. E.: Pharmacol Res 10, 317-327 (1993).
8. Tishmack, P. A., Bugay, D. E., Byrn, S. R.: J Pharm Sci 92, 441-474. (2003).
9. Berendt, R. T., Sperger, D. M., Isbester, P. K., munson, E. J.: Trends Anal Chem 25, 977-984. (2006).
10. Harris, R. K.: Analyst 131, 351-373. (2006).
11. Harris, R. K.: J Pharm Pharmacol 59, 225-239. (2007).
12. Geppi, M., Mollica, G., Borsacchi, S., Veracini, C. A.: Appl Spectrosc Rev 43, 202-302. (2008).
13. Szalontay, G.: Szilárdfázisú NMR (ss-NMR) vizsgálatok. In: Farkas, B., Révész, P. (Eds.): Kristályosítástól a tablettázásig - Anyagvizsgálati modszerek es technológiai eljárások kézikönyve. Universitas Szeged Kiadó, Szeged (2007)
14. Bak, M., Rasmussen, J.T., Nielsen, N.C: J Magn Reson 147, 296-330. (2000).
15. Hayashi, Sh., Hayamizu, K.: Bulletin of the Chemical Society of Japan 64, 685-687. (1991.
16. Duer, M. J.: Introduction to Solid-State NMR Spectroscopy. Blackwell Publishing Ltd. UK (2004).
17. Laws, D. D., Bitter, H-M. L., Jerschow, A.: Angew Chem Int Edit 41, 3096-3129. (2002).
18. http: //www.udel.edu/dybowski/research.htm - hozzáférés: 2010. márc.15.
19. Brown, S. P., Emsley, L.: Solid-sate NMR. In: Vo-Dinh, T., Gauglitz G. (Eds.): Handbook of Spectroscopy Vol. 2: NMR spectroscopy. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim (2003)
20. Harris, R. K., Becker, E. D., De Menezes, S. M. C., Granger, P., Hoffman, R. E., Zilm, K. W.: Pure Appl Chem 80, 59-84. (2008).
21. Emsley, L.; Laws, D. D.; Pines, A.: Lectures on Pulsed NMR (3rd ed.) In: Maraviglia, B., (Ed.): The Proceedings of the International School of Physics "Enrico Fermi", Course CXXXIX. p.45-210. IOS Press, Amsterdam, (1999)
22. Schurko R.: Introduction to solid-state NMR. Notes. http://mutuslab.cs. uwindsor.ca/schurko/ssnmr/ssnmr-schurko.pdf- hozzáférés: 2010.márc.15.
23. Samoson, A., Pines, A.: Rev Sci Instrum 60, 3239-3241. (1989).
24. Samoson, Á., Lippmaa, E., Pines, A.: Mol Phys 65, 1013-1018. (1988).
25. Llor, Á., Virlet, J.: Chem Phys Lett 152, 248-253. (1988).
26. Mueller, K. T., Sun, B. Q., Chingas, G. C., Zwanziger, J. W., Terao, T., Pines, A.: J Magn Reson 86, 470-487. (1990).
27. Bloch, F.: Phys Rev 111, 841-853. (1958).
28. Bennett, A. E., Rienstra, C. M., Auger, M., Lakshmi, K. V., Griffin, R. G.: J Chem Phys 103, 6951-6958. (1995).
29. Fung, B. M., Khitrin, A. K., Ermolaev, K.: J Magn Reson 142, 97-101. (2000).
30. Carravetta, M., Edén, M., Zhao, X., Brinkmann, A., Levitt, M. H.: Chem Phys Lett 321, 205. (2000)
31. Ernst, M., Zimmerman, H., Meier, B. H.:: Chem Phys Lett 317, 581-588. (2000).
32. Hartmann, S. R., Hahn, E. L.: Phys Rev 128, 2042-2053. (1962).
33. Taylor, R. E.: Concept Magn Reson A 22A(1), 37-49. (2004).
34. Taylor, R. E.: Concept Magn Reson A 22A(2), 79-89. (2004)
35. Opella, S. J., Frey, M. H.: J Am Chem Soc 102, 5854-5856. (2979).
36. Saindon, P. J.: Solid pharmaceuticals: Analysis and identification by solid state carbon-13 NMR. Doktori értekezés, Purdue University, West Lafayette, Indiana, U.S. (1992)
37. Saindon, P. J., Cauchon, N. S., Sutton, P. A., Chang, C.-J., Peck, G. E., Byrn, S. R.: Pharmacol Res 10, 197-203. (1993).
38. Wu, X., Zilm, K. W.: J Magn Reson A 102, 205-213. (1993).
39. Wu, X.; Burns, S. T., Zilm, K. W.: J Magn Reson A 111, 29-36. (1994).
40. http://nmr900.ca/testspectra-e.html hozzáférés: 2010. márc. 15.
41. Waugh, J. S., Huber, L. M., Haeberlen, U.: Phys Rev Lett 20, 180-182. (1968).
42. Mansfield, P.: J Phys C (Solid State Physics) 4, 1444-1452. (1971).
43. Rhim,W. K., Elleman, D. D., Vaughan, R. W.: J Chem Phys 58, 1772. (1973).
44. Burum, D. P., Rhim, W. K.: J Chem Phys 71, 944. (1979).
45. Cory, D. G.: Magn Reson 94, 526-534. (1992).
46. Lee, M. Goldburg, W.I.: Phys Rev 140, 1261-1271. (1965).
47. Bielecki, A., Kolbert, A. C., Levitt, M. K.: Chem Phys Lett 155, 341-346. (1989).
48. Bielecki, A., Kolbert, A. C., de Groot, H. J. M., Griffin, R. C., Levitt, M. H. In: Warren S. Warren (Ed.): Advances in Magnetic Resonance Vol. 14., p. 111. Academic Press (1990)
49. Vinogradov, E., Madhu, P. K., Vega, S.: Chem Phys Lett 314, 443-450. (1999).
50. Lesage, A., Duma, L., Sakellariou, D., Emsley, L.: J Am Chem Soc 123, 5747-5752. (2001).
51. Brown, S. P.: Prog Nucl Magn Res Sp 50, 199-251. (2007).
52. Griffin, J. M., Martin, D. R., Brown, S. P.: Angew Chem Int Edit 46, 8036-8038. (2007).
53. Morcombe, C. R., Zilm, K. W.: J Magn Res 162, 479-486. (2003).
54. Potrzebowski M. J., Tekely P., Dusausoy Y.: Solid State Nucl Magn Res 11, 253-257. (1998).
55. Dybowski, C., Neue, G.: Prog Nucl Magn Res Sp 41, 153-170. (2002).
56. Mildner, T., Ernst, H., Freude, D.: Solid State Nucl Magn Res 5, 269-271. (1995).
57. Ziarelli, T., Caldarelli, S.: Solid State Nucl Magn Res 29, 214-218. (2006).
58. Jelinek, R., Valente, A. P., Valentine, K. G., Opella, S. J..: J Magn Res 125, 185-187. (1997).
59. Svensson, A., Bergquista, K-E., Fex, T., Kihlberg, J.: Tetrahedron Lett 39, 7193-7196. (1998).
60. Elbayed, K., Bourdonneau, M., Furrer, J., Richert, Th., Raya, J., Hirschinger, J., Piotto, M.: J Magn Res 136, 127-129. (1999).
61. Silva, E. T., Câmara, C. A., San Gil, R. A. S., Fraga, C. A. M., Barreiro, E. J.: Annu Magn Res 5, 34-40. (2006).
62. Ramadhar, T. R., Amador, F., Ditty, M. J. T., Power, W. P.: Magn Res Chem 46, 30-35. (2008).
63. Lam, Y. H., Wassail, S. R., Morton, C. J., Smith, R., Separovic, R: Biophys J 82, 2752-2761. (2001).
64. Ader, C., Schneider, R., Seidel, K., Etzkorn, M., Baldus, M.: Biochem Soc T 35, 991-995. (2007).
65. Kajiya, K., Kumazawa, Sh., Naito, A., Nakayama, T.: Magn Res Chem 46, 174-1147 (2008).
66. Changsan, N., Chan, H-K., Separovic, F., Srichana, T.: J Pharm Sci 98, 628-639. (2009).
67. Jensen, M., Bjerring, M., Nielsen, N. Ch., Nerdal, W.: J Biol Inorg Chem 15, 213-223. (2010).
68. Agrawal, P., Kühne, S., Hollander, J., Hofmann, M., Langosch, D., de Groot, H.: Biochim Biophys Acta - Biomembranes 1798, 202-209. (2010)
69. Watts, A., Straus, S. K., Grage, S. L., Kamihira, M., Lam, Y. H., Zhao, X.: Methods Mol Biol 278, 403-473. (2004).
70. Lorch, M., Fahem, S., Kaiser, C., Weber, I., Mason, A. J., Bowie, J. U., Glaubitz, C.: Chem BioChem 6, 1693-1700. (2005).
71. Kijac, A. Z., Li, Y., Sligar, S. G., Rienstra, C. M.: Biochem 46, 13696-13703. (2007).
72. Li, Y., Berthold, D. A., Frericks, H. L., Gennis, R. B., Rienstra, C. M.: Chem BioChem 8, 434-442. (2007).
73. Li, Y., Berthold, D. A., Gennis, R. B., Rienstra, C. M.: Protein Sci 27, 199-204. (2008).
74. Wickham, J. R., Rice, Ch. V.: Solid State Nucl Magn Res 34, 154-161. (2008).
75. 75: Li, W.: Analyst 131, 777-781. (2006).
76. Bryant, P. L., Lukiw, W. J., Gan, Zh., Hall, R. W., Butler, L. G.: J Magn Res 170, 257-262. (2004).
77. Zernia, G., Huster, D.: Investigation of collagen dynamics by solid-state NMR spectroscopy. In: Webb, G. A. (Ed.): Modern Magnetic Resonance, p. 87-92. Springer Netherlands (2006).
78. Wilson, E. E., Awonusi, A., Morris, M. D., Kohn, D. H., Tecklenburg, M. M. J., Beck, L. W.: Biophys J 90, 3722-3731. (2006).
79. Grant, D. J. W.: Theory and origin of polymorphism. In H. G. Brittain (ed.) Polymorphism in Pharmaceutical Solids. Marcel Dekker, Inc., New York, pp. 1-34. (1999)
80. Nk, M., Jirat, J., Kosata, B.: Online corrected version of: "McNaught, A. D., Wilkinson, A.: IUPAC. Compendium of chemical terminology, 2nd ed. (the "Gold Book"). Blackwell Scientific Publications, Oxford (1997)", http: //goldbook.iupac.org - hozzáférés: 2009. nov. 20.; ISBN 0-9678550-9-8. doi:10.1351/goldbook.A00243. (2006).
81. Jensen W.B.: J Chem Educ 83, 838-839. (2006).
82. Wada, Y., Matsubara, T.: Powder Technol 78, 109-114. (1994).
83. Kristl, A., Srcic, S., Vrecer, F., Sustar, B., Vojnovic, D.: Int J Pharm 139, 231-235. (1996).
84. Bettinetti, G., Sorrenti, M., Catenacci, L., Ferrari, F., Rossi, S.: J Pharmaceut Biomed Anal 41, 1205-1211. (2006).
85. Kukovec, B-M., Popovic, Z.: J Mol Struct 930, 121-125. (2009).
86. Brittain, H. G.: J Pharm Sci 96, 705-728. (2007).
87. Brittain, H. G.: J Pharm Sci 97, 3611-3636. (2008).
88. Brittain, H. G., J Pharm Sci 98, 1617-1642 (2009).
89. Nangia, A.: Accounts Chem Res 42, 595-604. (2008).
90. Smith, J. R., Xu, W., Raftery, D.: J Phys Chem B 220, 7766-7776. (2006).
91. Henck, J-O., Kuhnert-Brandstatter, M.: J Pharm Sci 88, 103-108. (1999).
92. Burger, A., Ramberger, R.: Microchim Acta 72, 259-271. (1979).
93. Burger, A., Ramberger, R.: Microchim Acta 72, 273-316. (1979).
94. Aguiar, A. J., Krc, J. Jr., Kinkel, A. W., Samyn, J. C: J Pharm Sci 56, 847-853. (1967).
95. Miyazaki, S., Arita, T., Hori, R., Ito, K.: Chem Pharm Bull 22, 638-642. (1974).
96. Khalafallah, N., Khalil, S. A., Moustafa, M. A.: J Pharm Sci 63, 861-864. (1974).
97. Kobayashi, Y., Ito, S., Itai, S., Yamamoto, K.: Int J Pharm 193, 137-146. (2000).
98. Kalo, Y., Kohketsu, M.: Chem Pharm Bull 29, 268-272. (1981).
99. Higuchi, W. I., Lau, P. K., Higuchi, T., Shell, J. W.: J Pharm Sci 52, 150-153. (1963).
100. Higuchi, W. I., Bernardo, P. D., Mehta, S. C.: J Pharm Sci 56, 200-207. (1967).
101. Bod, P., Harsanyi, K., Hegedus, B., Bogsch, E., Fekecs, É., Peter, I., Aracs, Zs., Miszori, S., Stiller, M.: Morphologically homogenous forms of famotidine and processes for their preparation. Richter Gedeon Vegyészet - European Patent EP0256747 (1986).
102. Byrn, S., Pfeiffer, R., Ganey, M., Hoiberg, C., Poochikian, G.: Pharmacol Res 12, 945-954. (1995).
103. ICH Topic Q 6 A specifications: Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances. European Medicines Agency (2000).
104. Guidance for Industry ANDAs: Pharmaceutical solid polymorphism chemistry, Manufacturing, and controls Information. U.S. Department of Health and Human Services - Food and Drug Administration - Center for Drug Evaluation and Research (2007).
105. Sotthivirat, S., Lubach, J. W., Haslam, J. L., Munson, E. J., Stella, V. J.: J Pharm Sci 96, 1008-1017. (2007).
106. Dukić, A., Mens, R., Adriaensens, P., Foreman, P., Gelan, J., Remon, J. P., Vervaet, Ch.: Eur J Pharm Biopharm 66, 83-94. (2007).
107. Harris, R. K., Hodgkinson, P., Larsson, T., Muruganantham, A.: J Pharmaceut Biomed Anal 38, 858-864. (2005).
108. Kameda, T.: J Phys D - Applied Physics 38, 4313-4320. (2005).
109. Kameda, T., Tamada, Y.: Int J Biol Macromol 44, 64-69. (2009).
110. Campos, R., Ollivon, M., Marangoni, A. G.: Crystal Growth Des 10, 205-217. (2010).
111. Pouyani, T., Harbison, G. S., Prestwich, G. D.: J Am Chem Soc 116, 7515-7522. (1994).
112. Diez-Pena, E., Quijada-Garrido, I., Barrales-Rienda, J. M., Schnell, I., Spiess, H. W.: Macromol Chem Phys 205, 430-437. (2004).
113. Diez-Pena, E., Quijada-Garrido, I., Barrales-Rienda, J. M., Schnell, I., Spiess, H. W.: Macromol Chem Phys 205, 438-447. (2004).
114. Garcia, H., Barros, A. S., Gonçalves, C., Gama, F. M., Gil, A. M.: Eur Polym J 44, 2318-2329. (2008).
115. Capitani, D., De Angelis, A. A., Crescenzi, V., Masci, G., Segre, A. L.: Carbohyd Polym 45, 245-252. (2001).
116. Lumbach, J. W., Xu, D., Degmüller, B. E., Munson, E. J.: J Pharm Sci 96, 777-787. (2007).
117. Yoshinari, T., Forbes, R. T., York, P., Kawashima, Y.: Int J Pharm 247, 69-77. (2002).
118. Aldén, M., Lydén, M., Tegenféldt, J.: Int J Pharm 110, 267-276. (1994).
119. Vachon, M. G., Nairn, J. G.: Eur J Pharm Biopharm 45, 9-21. (1998).
120. Kimura, K., Hirayama, F., Arima, H., Uekama, K.: Pharmacol Res 16, 1729-1734. (1999).
121. Pignatello, R., Ferro, M., de Guidi, G., Salemi, G., Vandelli, M. A., Guccione, S., Geppi, M., Forte, C., Puglisi, G.: Int J Pharm 218, 27-42. (2002).
122. Puttipatkhachorn, S., Nunthanid, J., Yamamoto, K., Peck, G. E.: J Control Release 75, 143-153. (2001).
123. Byrn, S. R., Xu, W., Newman, A. W.: Adv Drug Deliver Rev 48, 115-136. (2001).
124. Zhu, L., Kumar, V., Banker, G. S.: Int J Pharm 223, 35-47. (2001).
125. Wulff, M., Aldén, M., Tegenfeldt, J.: Bioconjugate Chem 13, 240-248. (2002).
126. Schachter D. M., Xiong, J., Tirol G. C.: Int J Pharm 281, 89-101. (2004).
127. Babonneau, F., Yeung, L., Steunou, N., Gervais, C., Ramila, A., Vallet-Regi, M.: J Sol-Gel Sci Techn 31, 219-223. (2004).
128. Wissing, S. A., Müller, R. H., Manthei, L., Mayer, C.: Pharmacol Res 22, 400-405. (2004).
129. Chen, J.-Z., Ranade, S. V., Xie, X.-Q.: Int J Pharm 305, 129-144. (2005).
130. Chen, X., Griesser, U. J., Te, R. L., Pfeiffer, R. R., Morris, K. R., Stowell, J. G., Byrn, S. R.: J Pharm Biomed Anal 38, 670-677. (2005).
131. Geppi, M., Guccione, S., Mollica, G., Pignatello, R., Veracini, C. A.: Pharmacol Res 22, 1544-1555. (2005).
132. Mollica, G., Geppi, M., Pignatello, R., Veracini, C. A.: Pharmacol Res 23, 2129-2140. (2006).
133. Pongpeerapat, A., Higashi, K., Tozuka, Y., Moribe, K., Yamamoto, K.: Pharmacol Res 23, 256-2574. (2006).
134. Aso, Y., Yoshioka, S.: J Pharm Sci 95, 318-325. (2006).
135. Bibby, D. C., Davies, N. M., Tucker, I. G.: Int J Pharm 180, 161-168. (1999).
136. Aso, Y., Yoshioka, S., Zhang, J., Zografi, G.: Chem Pharm Bull 50, 822-826. (2002)
137. Wang, L.-F/, Chen, W. B., Chen, T.-Y., Lu, S. C.: J Biomat Sci-Polym Ed 14, 27-44. (2003).
138. Nakama, T., Ooya, T., Yui, N.: Polym J 36, 338-344. (2004).
139. Remenar, J. F., Wenslow, R., Ostovic, D., Peresypkin, A: Pharmacol Res 22, 185-188. (2004)
140. Antal, L., Zelkó, R.: Acta Pharm Hung 78, 121-133. (2008).
141. Ziarelli, F., Viel, S., Sanchez, S., Cross, D., Caldarelli, S.: J Magn Reson 188, 260-266. (2007).
142. Sanchez, S., Ziarelli, F., Viel, S., Delaurent C., Caldarelli, S.: J Pharm Biomed Anal 47, 683-687. (2008).
143. Hegeducombining double acute accents, B., Bod, P., Harsányi, K., Péter, L., Kálmán, A., Parkanyi, L.: Pharm Biomed Anal 7, 563-569. (1989).
144. Ferenczy, G, Párkányi, L, Ángyán J. G., Kálmán A., Hegeducombining double acute accents, B.: J Mol Struct (Theochem.) 503, 73-79. (2000).
145. Braun, D. E., Gelbrich, T., Kahlenberg, V., Tessadri, R., Wieser, J., Griesser, U. J.: J Pharm Sci 98, 2010-2026. (2009).
146. Német, Z.: Gyógyszervegyületek szilárdfá zisú analízise - A polimorfia kutatás korszerucombining double acute accent módszerei a gyógyszeriparban. (3.1.2. fejezet) PhD értekezés Richter Gedeon NyRt., Budapesti Mucombining double acute accentszaki Egyetem VBK (2009)
147. Xu, M., Harris, K. D. M.: J Am Chem Soc 127, 10832-10833. (2005),
148. Aslam, F., Cowans, B., Byrn, S. R., Stahly, G. P.: Polymorphs of zaleplon and methods for the preparation thereof. American Home Products Corporation - World Patent WO 02/12244 (2002)
149. Fehér, E., Korodi, F., Singer, C., Magyar, E.: Process for the purifying of N-[3-(3-cyanopyrazolo[1,5-A]pyrimidin-7-yl)phenyl]-N-ethylacetamide (Zaleplon). Teva Pharmaceuticals - World Patent WO 03/011228 (2002)
150. Bugay, D. E., Findlay, W. P.: Pharmaceutical Excipients. Marcel Dekker Inc. New York (1999)